Lecture Hall Diabetic Foot | Analysis

Risk Evaluation and Management of the Diabetic Foot

Available Credits
CME 0.75
CPME 0.75

John Steinberg
John Steinberg, DPM
Editor, PRESENT
Assistant Professor
Department of Plastic Surgery
Georgetown University School of Medicine
Washington, DC
This presentation was made possible
by a generous grant from
Coloplast
System Requirements Method of Participation Disclosure Information

Dr. John Steinberg provides an overview of the associated risk factors and proper evaluation of diabetic foot ulcerations. The lecture begins by discussing the epidemiology and economic impact of diabetes and diabetic foot ulcers. He then addresses the screening questions one should ask when evaluating the diabetic foot. Amputation risk factors such as infection and limb ischemia are also covered. Finally, the importance and application of the University of Texas Foot Risk and Diabetic Wound Classification Systems are explained in detail.

Goal and Objective
After participating in this activity, the viewer should be better able to:
1. Discuss the epidemiology of diabetes and amputations.
2. Describe the methods of assessing risk.
3. Relate the University of Texas classification.
4. Interpret the role of wound depth

Estimated time to complete this activity is 38 minutes.

Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Mount Sinai School of Medicine designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.n/a

Release Date: 01/01/2007 Expiration Date: 12/31/2010
Peer Review: on 01/01/2007
Activity Number: n/a

The Ohio College of Podiatric Medicine (OCPM) is an approved sponsor of Continuing Podiatric Medical Education through the Council on Podiatric Medical Education (CPME).

The Ohio College of Podiatric Medicine credits this activity for 0.75 credit hour.n/a

Release Date: 01/01/2007 Expiration Date: 12/31/2010
Peer Review: on 01/01/2007
Activity Number: n/a

System Requirements
Risk Evaluation and Management of the Diabetic Foot
Top
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures. While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback. You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox, or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials. For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
Method of Participation
Risk Evaluation and Management of the Diabetic Foot
Top
Complete the 4 steps to earn CE/CME credit:
  • Complete and submit the required pre-test
  • View Lecture
  • Complete and submit post-test and program evaluation. Credit will be issued with a passing score of 70% or better.
  • Click Print Certificate.
Disclosure Information
Risk Evaluation and Management of the Diabetic Foot
Top
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
John Steinberg, DPM has disclosed that he receives Honorarium/Expenses from Organogenesis, Integra, KCI and Smith & Nephew. He receives Grant/Research Support from Genentech, KCI and Organogenesis. He also serves as a Consultant to Integra and PRESENT, LLC. He is a member of the Merck, Pfizer and Johnson & Johnson Speaker's Bureaus.